Gryphon Financial Partners LLC Purchases 2,653 Shares of CVS Health Co. (NYSE:CVS)

Gryphon Financial Partners LLC lifted its position in CVS Health Co. (NYSE:CVSFree Report) by 48.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 8,151 shares of the pharmacy operator’s stock after buying an additional 2,653 shares during the period. Gryphon Financial Partners LLC’s holdings in CVS Health were worth $654,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Checchi Capital Advisers LLC increased its position in shares of CVS Health by 2.3% in the 3rd quarter. Checchi Capital Advisers LLC now owns 10,405 shares of the pharmacy operator’s stock valued at $726,000 after buying an additional 233 shares in the last quarter. Personal CFO Solutions LLC increased its holdings in CVS Health by 2.6% during the 3rd quarter. Personal CFO Solutions LLC now owns 19,355 shares of the pharmacy operator’s stock worth $1,351,000 after purchasing an additional 491 shares in the last quarter. Riverpoint Wealth Management Holdings LLC bought a new position in CVS Health during the 4th quarter worth about $218,000. Meritage Portfolio Management increased its holdings in CVS Health by 30.6% during the 4th quarter. Meritage Portfolio Management now owns 66,322 shares of the pharmacy operator’s stock worth $5,237,000 after purchasing an additional 15,548 shares in the last quarter. Finally, Ancora Advisors LLC increased its holdings in CVS Health by 17.5% during the 3rd quarter. Ancora Advisors LLC now owns 457,267 shares of the pharmacy operator’s stock worth $31,926,000 after purchasing an additional 68,005 shares in the last quarter. Institutional investors own 80.66% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on CVS. Mizuho lowered their target price on CVS Health from $86.00 to $72.00 and set a “buy” rating for the company in a report on Thursday, May 2nd. Wells Fargo & Company reduced their price objective on shares of CVS Health from $76.00 to $60.00 and set an “equal weight” rating for the company in a research note on Tuesday, May 7th. Robert W. Baird started coverage on shares of CVS Health in a research note on Thursday. They set a “neutral” rating and a $61.00 price objective for the company. Piper Sandler increased their price objective on shares of CVS Health from $93.00 to $94.00 and gave the stock an “overweight” rating in a research note on Friday, March 15th. Finally, Royal Bank of Canada reduced their price objective on shares of CVS Health from $86.00 to $84.00 and set an “outperform” rating for the company in a research note on Thursday, February 8th. Eleven investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $75.05.

Get Our Latest Stock Analysis on CVS

CVS Health Stock Up 6.4 %

Shares of CVS opened at $59.60 on Friday. CVS Health Co. has a 12 month low of $52.77 and a 12 month high of $83.25. The firm’s 50 day moving average is $64.87 and its 200-day moving average is $71.50. The stock has a market capitalization of $74.82 billion, a PE ratio of 10.47, a P/E/G ratio of 0.53 and a beta of 0.56. The company has a current ratio of 0.81, a quick ratio of 0.61 and a debt-to-equity ratio of 0.78.

CVS Health (NYSE:CVSGet Free Report) last announced its earnings results on Wednesday, May 1st. The pharmacy operator reported $1.31 EPS for the quarter, missing the consensus estimate of $1.69 by ($0.38). CVS Health had a return on equity of 13.53% and a net margin of 2.03%. The business had revenue of $88.44 billion for the quarter, compared to the consensus estimate of $89.33 billion. During the same period in the prior year, the business posted $2.20 earnings per share. The firm’s revenue for the quarter was up 3.7% compared to the same quarter last year. Equities research analysts forecast that CVS Health Co. will post 7.02 EPS for the current year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, May 1st. Stockholders of record on Monday, April 22nd were issued a dividend of $0.665 per share. The ex-dividend date was Friday, April 19th. This represents a $2.66 annualized dividend and a dividend yield of 4.46%. CVS Health’s dividend payout ratio is presently 46.75%.

Insider Transactions at CVS Health

In other news, Director Edward J. Ludwig acquired 1,000 shares of the firm’s stock in a transaction that occurred on Thursday, May 2nd. The shares were acquired at an average cost of $53.88 per share, with a total value of $53,880.00. Following the completion of the purchase, the director now directly owns 21,630 shares of the company’s stock, valued at approximately $1,165,424.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.24% of the company’s stock.

CVS Health Company Profile

(Free Report)

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Featured Articles

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVSFree Report).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.